CINCINNATI VA MEDICAL CENTER RESEARCH
Molecular Repair of Diabetic Mesenchymal Stem Cells (dMSC) for Peripheral Arterial Disease
Molecular Repair of Diabetic Mesenchymal Stem Cells (dMSC) for Peripheral Arterial Disease is a funding opportunity from CINCINNATI VA MEDICAL CENTER RESEARCH, closing September 30, 2028.
Sep 30, 2028
(792d left)Overview
Background and Innovation: Diabetes and ischemia lead to loss of neuromotor connections resulting in disability. Diabetic Veterans with PAD have significant therapeutic needs that are often incompletely addressed due to limitations in our understanding and therapeutic options. Functional recovery of ischemic muscle is…